Core Insights - The launch of the first cardiovascular AI-OCT large model in China represents a significant breakthrough in precision vascular interventional treatment (PCI) [1][2] - The AI-OCT model enhances the efficiency and accuracy of OCT imaging while lowering the technical barriers for its use in clinical settings [1][2] Group 1: Technology and Innovation - The麒光AI-OCT model overcomes multiple technical challenges, enabling intelligent recognition of critical features such as vulnerable plaques, calcification distribution, and stent apposition [2] - The system has a misdiagnosis rate lower than the average human physician and can generate results in seconds, significantly reducing the usage threshold for OCT technology [2] Group 2: Clinical Impact - Clinical trials indicate that the AI-OCT system excels in improving diagnostic consistency, shortening interpretation time, and assisting in surgical strategy formulation [2] - The AI-OCT model facilitates a transition from merely viewing images to generating actionable treatment plans, marking a shift towards intelligent medical diagnosis [2] Group 3: Data Quality and Compliance - The reliability of medical AI is fundamentally linked to the quality and compliance of the data used for training, as highlighted by industry experts [1] - The establishment of the East Wall Cardiovascular Corpus, which integrates data from 129 top journals and clinical data, aims to provide a high-quality data foundation for the AI-OCT model [1] Group 4: Accessibility and Equity - The AI-OCT model aims to democratize access to advanced diagnostic capabilities, addressing the disparity in diagnostic skills between grassroots hospitals and top-tier medical institutions [2] - The goal is to translate the expertise of top surgeons into accessible tools for broader healthcare equity, particularly in managing coronary artery disease [2]